Transcutaneous Electrical Nerve Stimulation Regulates Organ Blood Flow and Apoptosis during Controlled Hypotension in Dogs

Lele Zhang, Xiaomei Shao, Chuanlong Zhou, Xiaoqing Guo, Ling Jin, Lin-Li Lian, Xiao-Jing Yu, Zhenhua Dong, Ya-Di Mo, Jianqiao FangPLoS 2014 · DOI

Abstract

Transcutaneous electrical nerve stimulation (TENS) is commonly used in clinical practice for alleviating pain and physiological disorders. It has been reported that TENS could counteract ischemic injury in vital organs. To determine the protective effect of TENS on internal organs during controlled hypotension (CH) in dogs, target hypotension was maintained for 60 min at 50% of the baseline mean arterial pressure (MAP). The perfusion to the brain, liver, stomach, and kidney was recorded, and apoptosis within these organs was observed. Results showed that during the maintenance stage, perfusion to the stomach and liver in the CH+TENS group was significantly higher than in the CH group (P<0.05). After withdrawing CH, gastric and cerebral cortical blood flow in the CH+TENS group increased rapidly. Furthermore, TENS significantly reduced the number of TUNEL-positive (apoptotic) cells in stomach and kidney tissue compared to the CH-only group. Our results demonstrate that TENS combined with general anesthesia (GA) can improve blood flow to the liver and stomach and reduce apoptosis in the stomach and kidney during hypotensive states.

Introduction

In major surgical procedures, controlled hypotension (CH) is a vital technique used to reduce blood loss and provide a clearer surgical field. By deliberately lowering a patient’s mean arterial pressure (MAP), surgeons can minimize hemorrhage. However, this reduction in systemic pressure carries the risk of "hypoperfusion," where vital organs do not receive adequate oxygenated blood. This can lead to ischemic injury and trigger apoptosis (programmed cell death), particularly in sensitive organs like the brain, liver, and kidneys.

This study investigates whether Transcutaneous Electrical Nerve Stimulation (TENS), a non-invasive method typically used for pain relief, can act as a protective intervention. The researchers aimed to determine if TENS could modulate blood flow redistribution to protect these "innocent bystander" organs during a significant 50% drop in MAP.

Methods

The study utilized a canine model consisting of 18 beagle dogs divided into three experimental groups:

  1. GA Group: General anesthesia only (control).
  2. CH Group: General anesthesia + controlled hypotension (MAP reduced to 50% of baseline for 60 minutes using sodium nitroprusside).
  3. CH+TENS Group: General anesthesia + controlled hypotension + TENS applied to four bilateral acupuncture points: Hegu (LI4), Zusanli (ST36), Sanyinjiao (SP6), and Quchi (LI11). Stimulation began 30 minutes before and continued throughout the hypotensive period.
Anatomical locations of acupuncture points used for TENS application in the canine model.

Key Measurements: * Organ Perfusion: Real-time blood flow in the cerebral cortex, liver, kidney, and stomach was measured using Laser Doppler flowmetry at ten specific time points (T1–T10). * Apoptosis: 72 hours post-procedure, tissue samples from the hippocampus, liver, kidney, and stomach were analyzed using TUNEL staining to quantify programmed cell death.

Key Insights and Results

Selective Organ Vulnerability

The study revealed that organs react differently to hypotension. While the liver and hippocampus remained relatively resilient at a 50% MAP reduction, the stomach and kidneys showed a significant spike in apoptotic cells 72 hours after the procedure in the CH-only group.

TENS as a Circulatory Regulator

TENS intervention successfully buffered the drop in local blood flow. During the early maintenance of hypotension, the CH+TENS group maintained significantly higher blood flow in the stomach and liver compared to the CH group ($P < 0.05$). This suggests that TENS may modulate the autonomic nervous system or the endogenous opioid system to maintain organ perfusion.

Accelerated Recovery

A critical finding was the "recovery boost" provided by TENS. After the hypotensive period ended, TENS significantly accelerated the return of blood flow to the stomach and cerebral cortex. In contrast, gastric blood flow in the CH-only group remained low even after systemic blood pressure returned to baseline.

Inhibition of Cell Death

Most importantly, TENS effectively inhibited apoptosis. In the stomach and kidneys, where the CH group showed high levels of cell death, the CH+TENS group maintained apoptosis levels near those of the healthy GA control group.

Discussion and Limitations

While the study demonstrates the protective efficacy of TENS, several areas require further exploration:

  • Mechanism Specificity: The exact neurochemical pathways (e.g., specific neurotransmitters) involved in this protective effect remain partially speculative.
  • Clinical Translation: While beagle dogs are a standard cardiovascular model, human autonomic responses to TENS under anesthesia may vary.
  • Pressure Thresholds: Future research should investigate the "breaking point" where TENS may no longer be sufficient to protect organs at MAP reductions greater than 50%.
  • Long-term Outcomes: Apoptosis was measured at 72 hours; longer-term studies are needed to confirm if these cellular protections translate into improved clinical organ function weeks after surgery.

In conclusion, TENS combined with general anesthesia represents a promising, non-invasive strategy to improve organ perfusion and reduce ischemic damage during surgeries requiring controlled hypotension.

Summary updated

Abstract

Transcutaneous electrical nerve stimulation (TENS) is commonly used in clinical practice for alleviating pains and physiological disorders. It has been reported that TENS could counteract the ischemic injury happened in some vital organs. To determine the protective effect of TENS on internal organs during CH in dogs, target hypotension was maintained for 60 min at 50% of the baseline mean arterial pressure (MAP). The perfusion to the brain, liver, stomach, and kidney was recorded and apoptosis within these organs was observed. Results showed that when arriving at the target MAP, and during the maintaining stage for 10 min, perfusion to the stomach and liver in the CH+TENS group was much higher than in the CH group (P<0.05). Perfusion to the cerebral cortex greatly declined in both the controlled pressure groups when compared with the general anesthesia (GA) group (P<0.05). After withdrawing CH, the hepatic blood flow in both the CH and CH+TENS groups, and the gastric and cerebral cortical blood flow in the CH+TENS group, were rapidly increased. By the end of MAP restoration, gastric blood flow in the CH group was still low. At 72 h after applying CH, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL)-positive cells in stomach and kidney tissue from the CH group were significantly increased compared with those in the GA group (P<0.05). There was no significant difference in TUNEL-positive cells in the liver and hippocampus among the three groups. Our results demonstrated that CH with a 50% MAP level could cause lower perfusion to the liver, stomach, cerebral cortex, and kidney, with apoptosis subsequently occurring in the stomach and kidney. TENS combined GA is able to improve the blood flow to the liver, stomach, and reduce the apoptosis in the stomach and kidney.
BibTeX
@inproceedings{zhang2014transcutaneous,
  author = {Lele Zhang and Xiaomei Shao and Chuanlong Zhou and Xiaoqing Guo and Ling Jin and Lin-Li Lian and Xiao-Jing Yu and Zhenhua Dong and Ya-Di Mo and Jianqiao Fang},
  title = {{Transcutaneous Electrical Nerve Stimulation Regulates Organ Blood Flow and Apoptosis during Controlled Hypotension in Dogs}},
  booktitle = {PLoS},
  year = {2014},
  doi = {10.1371/journal.pone.0094368},
}
Figure